Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   
 

Abstract | Full HTML Article | PDF | Spanish ecancer 9 534 / https://doi.org/10.3332/ecancer.2015.534

Special Issue

The SUMO conjugating enzyme UBC9 as a biomarker for cervical HPV infections

Human papillomaviruses (HPVs) infect stratified epithelium and are the causative agents of cervical cancer, the second most common cause of cancer-related death in women. A critical aspect that still persists in the HPV field is the selection of very sensitive and specific HPV diagnostic assays. Here, we provide evidence that the crucial small ubiquitin-like modifier (SUMO) E2-conjugating enzyme Ubc9 is strongly upregulated in cervical lesions. Ubc9 detection could thus be used in diagnosing and/or monitoring the progression of an HPV oncogenic infection.

Keywords: Ubc9, SUMO, biomarker, HPV, LSIL, HSIL, cervical cancer

Loading Article Metrics ... Please wait

Related articles

Research: Creating a low-cost virtual reality surgical simulation to increase surgical oncology capacity and capability

Abstract | Full Article | PDF Published: 19 Mar 2019 / https://doi.org/10.3332/ecancer.2019.910

Review: Non-hormonal strategies for managing menopausal symptoms in cancer survivors: an update

Abstract | Full Article | PDF Published: 11 Mar 2019 / https://doi.org/10.3332/ecancer.2019.909

Case Report: Laser thermal ablation to treat a recurrent soft-tissue sarcoma of the leg: a case report

Abstract | Full Article | PDF Published: 05 Mar 2019 / https://doi.org/10.3332/ecancer.2019.908

Review: Petroclival meningiomas: radiological features essential for surgeons

Abstract | Full Article | PDF Published: 05 Mar 2019 / https://doi.org/10.3332/ecancer.2019.907

Research: Younger age and previous exposure to radiation therapy are correlated with the severity of chemotherapy-induced thrombocytopenia

Abstract | Full Article | PDF Published: 26 Feb 2019 / https://doi.org/10.3332/ecancer.2019.906



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation